Our pathways highlight best practices, from early diagnosis and intervention to long-term management and follow-up care. With an emphasis on multidisciplinary collaboration, these aim to enhance patient outcomes and ensure high-quality, co-ordinated care at every stage.
The new Cardiac Amyloidosis Diagnostic Pathway is now available to support healthcare professionals in Scotland in recognising and diagnosing cardiac amyloidosis more effectively.
This pathway provides a structured approach to identifying suspected cases, guiding diagnostic investigations, and facilitating specialist referrals.
Access the full document below to ensure timely and accurate diagnosis for patients at risk.
Based at NHS Golden Jubilee in Glasgow and is commissioned by National Services Division of the Scottish Government. They are responsible for providing advanced heart failure therapies to appropriate patients throughout Scotland, from the Borders to the Shetland Islands.
These therapies currently consist of cardiac transplantation, as well as recognised mechanical circulatory support (MCS) strategies, that are licensed as a “bridge” to transplant. These include veno-arterial extra-corporeal membrane oxygenation (VA-ECMO) and short-term and long-term ventricular assist devices (VADs).
The information contained in this website is for general information purposes only. While we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
